Clinical Decision Support for Hypertension Management in Chronic Kidney Disease
This randomized clinical trial evaluates a computerized clinical decision support system for the management of uncontrolled hypertension in patients with chronic kidney disease. (Source: JAMA Internal Medicine)
Source: JAMA Internal Medicine - March 11, 2024 Category: Internal Medicine Source Type: research
Inconclusive Findings in Non-Vitamin K Antagonist Oral Anticoagulants Study — In Reply
In Reply We appreciate the insights provided by Khan et al and Tzeng and Tsai regarding our study. As noted in the study limitations, although the use of prescription data from the claims database is superior to self-reported medication use, this method may not fully capture patient nonadherence, which could be a potential risk for misclassification. The best pragmatic approach to verify the time elapsed since the most recent dose of non −vitamin K antagonist oral anticoagulants (NOACs) is to use medication adherence monitoring devices (eg, ingestible electronic sensor) or noninvasive medication compliance monitoring sys...
Source: JAMA Internal Medicine - March 11, 2024 Category: Internal Medicine Source Type: research
Programming Error and Incorrect Denominators in a Study of Low-Value Health Services
To the Editor On behalf of my coauthors, I write to report errors that occurred in our Original Investigation, “Use and Cost of Low-Value Health Services Delivered or Paid for by the Veterans Health Administration,” that was published online first on July 5, 2022, and in the August 2022 issue of JAMA Internal Medicine. (Source: JAMA Internal Medicine)
Source: JAMA Internal Medicine - March 11, 2024 Category: Internal Medicine Source Type: research
Inconclusive Findings in Non-Vitamin K Antagonist Oral Anticoagulants Study
To the Editor We read with interest the nationwide population-based cohort study with meta-analysis by Tsai et al. The study findings showed that patients who received non-vitamin K antagonist oral anticoagulants (NOACs) before a stroke, compared with those receiving warfarin and those without oral anticoagulant treatment (non-OAC), did not experience a higher risk of intracranial hemorrhage (ICH), major bleeding events, or mortality when treated with intravenous alteplase for acute ischemic stroke. In comparison with the active comparator (warfarin group), the odds ratios (ORs) were 0.88 (95% CI, 0.32-2.40) for ICH, 0.82 ...
Source: JAMA Internal Medicine - March 11, 2024 Category: Internal Medicine Source Type: research
Inconclusive Findings in Non-Vitamin K Antagonist Oral Anticoagulants Study
To the Editor In their population-based cohort study using Taiwan ’s National Health Insurance Research Database, Tsai et al report no excess risk of intracranial hemorrhage (ICH) associated with treatment compared with no treatment with non-vitamin K antagonist oral anticoagulants (NOACs) in patients with acute ischemic stroke receiving intravenous alteplase. W e applaud the authors’ efforts to build on the evidence on the safety of thrombolysis in patients receiving NOACs; however, we wonder about potential issues of exposure and outcome misclassification producing results that are biased toward the null hypothesis. ...
Source: JAMA Internal Medicine - March 11, 2024 Category: Internal Medicine Source Type: research
Physician Perspectives on Private Equity Investment in Health Care
This survey study examines physician views toward private equity investment in health care. (Source: JAMA Internal Medicine)
Source: JAMA Internal Medicine - March 11, 2024 Category: Internal Medicine Source Type: research
Physicians in Private Equity Practices
Health Care Policy (Source: JAMA Internal Medicine)
Source: JAMA Internal Medicine - March 11, 2024 Category: Internal Medicine Source Type: research
Programming Error and Incorrect Denominators in a Sensitivity Analysis
In the Original Investigation, “Use and Cost of Low-Value Health Services Delivered or Paid for by the Veterans Health Administration,” that was published online first on July 5, 2022, and in the August 2022 issue of JAMA Internal Medicine, a programming error resulted in the use of incorrect service-specific denominators for the rates reported in eTable 4 in the Supplement. Corrections have been made to eTable 4 and the related text in the Results section of the article. The authors have published a Letter of explanation and confirmed that the error did not affect the main findings of the study. (Source: JAMA Internal Medicine)
Source: JAMA Internal Medicine - March 11, 2024 Category: Internal Medicine Source Type: research
Longitudinal Management of Dementia in Primary Care
This Viewpoint describes the positive role that primary care teams can play in the lives of patients with dementia and the families that care for them. (Source: JAMA Internal Medicine)
Source: JAMA Internal Medicine - March 4, 2024 Category: Internal Medicine Source Type: research
Dementia Prevention and Treatment
This Narrative Review summarizes current evidence and explores emerging science on the prevention and treatment of dementia to inform clinical decision-making. (Source: JAMA Internal Medicine)
Source: JAMA Internal Medicine - March 4, 2024 Category: Internal Medicine Source Type: research
The Strength It Takes to Suffer
This essay describes an intensive care and palliative medicine physician ’s decision to elect medical aid in dying. (Source: JAMA Internal Medicine)
Source: JAMA Internal Medicine - March 4, 2024 Category: Internal Medicine Source Type: research
I Am Worried About Memory Loss —What Should I Know?
This JAMA Internal Medicine Patient Page describes memory loss and dementia and how they may be treated. (Source: JAMA Internal Medicine)
Source: JAMA Internal Medicine - March 4, 2024 Category: Internal Medicine Source Type: research
Rapid Respiratory Viral Testing in Emergency Departments
This systematic review and meta-analysis examines the association of rapid respiratory virus testing in patients with suspected acute respiratory infection with decreased antibiotic use, ancillary tests, emergency department length of stay and return visits and hospitalization, and increased influenza antiviral treatment. (Source: JAMA Internal Medicine)
Source: JAMA Internal Medicine - March 4, 2024 Category: Internal Medicine Source Type: research
Catholic Hospital Affiliation and Postpartum Contraceptive Care and Subsequent Deliveries
This cohort study examines whether the probabilities of postpartum contraception and subsequent deliveries vary according to whether the closest hospital is a Catholic or non-Catholic hospital. (Source: JAMA Internal Medicine)
Source: JAMA Internal Medicine - March 4, 2024 Category: Internal Medicine Source Type: research
Complication Rates of Central Venous Catheters
This systematic review and meta-analysis summarizes current rates of central venous catheter –associated complications. (Source: JAMA Internal Medicine)
Source: JAMA Internal Medicine - March 4, 2024 Category: Internal Medicine Source Type: research
